These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 26613819

  • 1. A randomized trial of sublingual misoprostol to augment routine third-stage management among women at risk of postpartum hemorrhage.
    Chaudhuri P, Majumdar A.
    Int J Gynaecol Obstet; 2016 Feb; 132(2):191-5. PubMed ID: 26613819
    [Abstract] [Full Text] [Related]

  • 2. Sublingual misoprostol as an adjunct to oxytocin during cesarean delivery in women at risk of postpartum hemorrhage.
    Chaudhuri P, Majumdar A.
    Int J Gynaecol Obstet; 2015 Jan; 128(1):48-52. PubMed ID: 25277789
    [Abstract] [Full Text] [Related]

  • 3. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women.
    Chaudhuri P, Biswas J, Mandal A.
    Int J Gynaecol Obstet; 2012 Feb; 116(2):138-42. PubMed ID: 22100204
    [Abstract] [Full Text] [Related]

  • 4. Double-blind randomized controlled trial comparing misoprostol and oxytocin for management of the third stage of labor in a Nigerian hospital.
    Musa AO, Ijaiya MA, Saidu R, Aboyeji AP, Jimoh AA, Adesina KT, Abdul IF.
    Int J Gynaecol Obstet; 2015 Jun; 129(3):227-30. PubMed ID: 25835642
    [Abstract] [Full Text] [Related]

  • 5. Prevention of postpartum haemorrhage with sublingual misoprostol or oxytocin: a double-blind randomised controlled trial.
    Bellad MB, Tara D, Ganachari MS, Mallapur MD, Goudar SS, Kodkany BS, Sloan NL, Derman R.
    BJOG; 2012 Jul; 119(8):975-82; discussion 982-6. PubMed ID: 22703421
    [Abstract] [Full Text] [Related]

  • 6. Active Management of the Third Stage of Labor With a Combination of Oxytocin and Misoprostol to Prevent Postpartum Hemorrhage: A Randomized Controlled Trial.
    Quibel T, Ghout I, Goffinet F, Salomon LJ, Fort J, Javoise S, Bussieres L, Aegerter P, Rozenberg P, Groupe de Recherche en Obstétrique et Gynécologie (GROG).
    Obstet Gynecol; 2016 Oct; 128(4):805-11. PubMed ID: 27607864
    [Abstract] [Full Text] [Related]

  • 7. A randomized controlled trial of sublingual misoprostol and intramuscular oxytocin for prevention of postpartum hemorrhage.
    Priya GP, Veena P, Chaturvedula L, Subitha L.
    Arch Gynecol Obstet; 2015 Dec; 292(6):1231-7. PubMed ID: 25990482
    [Abstract] [Full Text] [Related]

  • 8. Misoprostol in addition to routine treatment of postpartum hemorrhage: a hospital-based randomized-controlled trial in Karachi, Pakistan.
    Zuberi NF, Durocher J, Sikander R, Baber N, Blum J, Walraven G.
    BMC Pregnancy Childbirth; 2008 Aug 21; 8():40. PubMed ID: 18718007
    [Abstract] [Full Text] [Related]

  • 9. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trial.
    Atukunda EC, Siedner MJ, Obua C, Mugyenyi GR, Twagirumukiza M, Agaba AG.
    PLoS Med; 2014 Nov 21; 11(11):e1001752. PubMed ID: 25369200
    [Abstract] [Full Text] [Related]

  • 10. Randomized controlled trial comparing 200μg and 400μg sublingual misoprostol for prevention of primary postpartum hemorrhage.
    Ugwu IA, Oluwasola TA, Enabor OO, Anayochukwu-Ugwu NN, Adeyemi AB, Olayemi OO.
    Int J Gynaecol Obstet; 2016 May 21; 133(2):173-7. PubMed ID: 26892695
    [Abstract] [Full Text] [Related]

  • 11. A randomised controlled trial of sublingual misoprostol and intramuscular oxytocin for prevention of postpartum haemorrhage.
    Al-Sawaf A, El-Mazny A, Shohayeb A.
    J Obstet Gynaecol; 2013 Apr 21; 33(3):277-9. PubMed ID: 23550857
    [Abstract] [Full Text] [Related]

  • 12. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial.
    Blum J, Winikoff B, Raghavan S, Dabash R, Ramadan MC, Dilbaz B, Dao B, Durocher J, Yalvac S, Diop A, Dzuba IG, Ngoc NT.
    Lancet; 2010 Jan 16; 375(9710):217-23. PubMed ID: 20060162
    [Abstract] [Full Text] [Related]

  • 13. Rectal misoprostol versus intravenous oxytocin for prevention of postpartum hemorrhage.
    Nasr A, Shahin AY, Elsamman AM, Zakherah MS, Shaaban OM.
    Int J Gynaecol Obstet; 2009 Jun 16; 105(3):244-7. PubMed ID: 19249048
    [Abstract] [Full Text] [Related]

  • 14. A pilot-randomized comparison of sublingual misoprostol with syntometrine on the blood loss in third stage of labor.
    Lam H, Tang OS, Lee CP, Ho PC.
    Acta Obstet Gynecol Scand; 2004 Jul 16; 83(7):647-50. PubMed ID: 15225189
    [Abstract] [Full Text] [Related]

  • 15. Sublingual misoprostol versus intravenous oxytocin in prevention of post-partum hemorrhage.
    Tewatia R, Rani S, Srivastav U, Makhija B.
    Arch Gynecol Obstet; 2014 Apr 16; 289(4):739-42. PubMed ID: 24045979
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Randomized controlled trial comparing 400μg sublingual misoprostol versus placebo for prevention of primary postpartum hemorrhage.
    Zgaya R, Ghadhab I, Triki MA, Briki R.
    Pan Afr Med J; 2020 Apr 16; 36():186. PubMed ID: 32952830
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.